Real-World Outcomes of Sequential Afatinib and Osimertinib Versus Afatinib and Chemotherapy in EGFR-Mutant NSCLC: Taiwan Multicenter GIANT Study
EGFR突变型非小细胞肺癌患者序贯阿法替尼联合奥希替尼与阿法替尼联合化疗的真实世界疗效:台湾多中心GIANT研究
期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-026-01203-6
Ko, How-Wen; Liao, Ying-Ting; Liang, Sheng-Kai; Huang, Yen-Hsiang; Lin, Yu-Ching; Liu, Ping-Chi; Wang, Chin-Chou; Tsai, Jeng-Shiuan; Chen, Yuh-Min; Shih, Jin-Yuan; Yang, Tsung-Ying; Yang, Chang-Ta